Cardionomic
Innovative therapies for acute decompensated heart failure, enhancing patient outcomes and reducing readmissions.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor investor investor | €0.0 | round | |
| N/A | $5.0m | Debt | |
| Total Funding | 000k | ||
Related Content
Cardionomic Inc. is a medical technology company focused on developing innovative therapies for acute decompensated heart failure (ADHF). Operating in the healthcare sector, Cardionomic serves hospitals and healthcare providers by offering advanced treatment solutions designed to improve patient outcomes and reduce costly readmissions. The company's core product aims to bridge the gap between evidence and practice in ADHF management, enhancing pharmacological tolerance at discharge and extending patient life expectancy. Cardionomic's business model revolves around the development and commercialization of its proprietary therapies, generating revenue through product sales and strategic partnerships with healthcare institutions.
Keywords: acute decompensated heart failure, innovative therapies, patient outcomes, readmission reduction, healthcare providers, medical technology, pharmacological tolerance, hospital solutions, life extension, strategic partnerships.